Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05431894 · ClinicalTrials.gov registry record · NA

Behavioral and Recovery Support for 30 Day Post-Discharge Care

A NA study of Cardiovascular Diseases, sponsored by Laguna Health.

Completed
Registry status
NA
Development phase
408
Enrollment target
1
Study location

NCT05431894 is a NA study of Cardiovascular Diseases that has completed, run by Laguna Health. The registered enrollment target is 408 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05431894, a NA study of Cardiovascular Diseases, has completed, sponsored by Laguna Health.

COMPLETED
Registry status
NA
Development phase
408 participants
Enrollment target
1
Study location

Study Summary

This study will provide behavioral and mental health support to a select group of participants to supplement the hospital-provided discharge and recovery plans, based on clinical guidance and dedicated post-hospitalization behavioral protocols, with the goals of reducing readmission rates and costs.

Conditions Studied

Interventions

  • BEHAVIORAL Laguna Coach Intervention Group

Study Locations (1)

Illinois

  • NorthShore University HealthSystem - Evanston

Trial Details

FieldValue
Enrollment Target 408 participants
Start Date 2021-02-18
Est. Completion 2022-06-13
Phase NA

Sponsor

Laguna Health

2 total trials

What the Registry Record Tells You About NCT05431894

The ClinicalTrials.gov registry entry for NCT05431894 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 408 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (98% lower). The listed sponsor is Laguna Health, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Laguna Coach Intervention Group is the first listed.

NCT05431894 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05431894 about?

NCT05431894 is a clinical study titled "Behavioral and Recovery Support for 30 Day Post-Discharge Care". This study will provide behavioral and mental health support to a select group of participants to supplement the hospital-provided discharge and recovery plans, based on clinical guidance and dedicated post-hospitalization behavioral protocols, with the goals of reducing readmission rates and costs.

What is the current status of trial NCT05431894?

This trial is currently completed. It is a NA study. The enrollment target is 408 participants. The study started on 2021-02-18. Estimated completion is 2022-06-13.

What conditions does trial NCT05431894 study?

This clinical trial studies the following conditions: Cardiovascular Diseases.

What interventions are being tested in trial NCT05431894?

The interventions under investigation include: Laguna Coach Intervention Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT05431894?

This trial is sponsored by Laguna Health, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05431894 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.